CSA Releases Results of Tenth Gender Diversity Review
On October 30, 2024, the Canadian Securities Administrators (CSA) released CSA Multilateral Staff Notice 58-317 – Review of Disclosure Regarding Women on Boards and in Executive Officer Positions, which outlines key trends from the CSA’s most recent review of gender diversity disclosure by non-venture issuers. This tenth and likely final diversity review completed by the CSA under the current disclosure standards reveals that the proportion of women on boards and in executive officer positions among such issuers continues to trend upward.
The CSA is exploring potential changes to diversity-related disclosure requirements, as outlined in its April 2023 notice and request for comment regarding proposed amendments to Form 58-101F1 Corporate Governance Disclosure of National Instrument 58-101 – Disclosure of Corporate Governance Practices (“NI 58-101”) and proposed changes to National Policy 58-201 – Corporate Governance Guidelines (“NP 58-201”).
Current Regulations and Potential Changes
Since 2015, NI 58-101 has required all non-venture issuers to disclose certain information regarding gender diversity among its board of directors and executive officers. These requirements aim to increase transparency for investors and other stakeholders regarding the representation of women on boards and in executive officer positions, and the approach issuers take in respect of such representation.
The gender diversity disclosure requirements in NI 58-101 currently consists of a “comply or explain” regime under which issuers must disclose, among other things:
- the number and percentage of women on its board of directors and in executive officer positions,
- whether the issuer has targets for the number or percentage of women in board and executive officer positions (and if not, why not),
- whether the issuer has a written policy relating to the identification and nomination of female directors (and if not, why not), and
- whether consideration is given to female representation in the director and officer recruitment process.
If implemented, the proposed changes to NI 58-101 and NP 58-201 would expand diversity disclosure requirements for non-venture issuers and provide enhanced (non-prescriptive) guidelines for all issuers, including with respect to adoption of a written diversity policy and setting diversity objectives (e.g., numerical targets and training programs).
For further details about the potential amendments, see our April 17, 2023 Update, Canadian Securities Administrators Proposes Amendments and Changes to Corporate Governance Disclosure Practices and Guidelines.
Key Trends
In its tenth consecutive gender diversity review, the CSA reviewed the gender diversity disclosure of 574 issuers that had year-ends between December 31, 2023 and March 31, 2024.
Some of the key trends highlighted in the report include:
- Women currently occupy 29% of director positions (up from 27% in 2023 and 11% in 2015),
- 37% of vacated board seats were filled by women in 2023 (down from 43% in 2023 but up from 26% in 2017),
- 90% of issuers have at least one woman on their board (up from 89% in 2023 and 49% in 2015),
- 44% of issuers have adopted targets for the representation of women on their boards (up from 43% in 2023 and 7% in 2015), with those issuers having an average of 35% of their board seats held by women (compared to an average of 22% for issuers without targets),
- 64% of issuers have adopted policies for identifying and nominating female directors (unchanged from 2023, but up from 15% in 2015), with those issuers having an average of 33% of their board seats held by women (compared to an average of 20% for issuers with no such policy),
- Issuers with director term limits or other board renewal mechanisms generally have more women on their boards (35% for issuers that have adopted term limits compared to 26% for issuers with no such limits; 29% for issuers with alternative mechanisms for board renewal compared to 23% for issuers with no such mechanisms in place), and
- Only 5% of issuers have a female CEO and 16% have a female CFO.
Guidance from Proxy Advisory Firms
Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co. will recommend a vote against the chair of the nominating committee of a S&P/TSX Composite Index or TSX issuer, respectively, whose board is comprised of less than 30% women. The latest guidelines published by ISS also include racial and ethnic diversity guidance and, in particular, indicate that a vote against recommendation in respect of the chair of the nominating committee will be made where a S&P/TSX Composite Index issuer board has no apparent racially or ethnically diverse members and the company has not provided a formal, publicly-disclosed written commitment to add at least one racially or ethnically diverse director at or prior to its next annual general meeting.
For further details about current ISS and Glass Lewis guidance, see our December 20, 2023 Update, ISS and Glass Lewis Update Canadian Proxy Voting Guidelines for 2024.
Future of Gender Diversity in Canada
The representation of women among issuers, and for board positions in particular, has improved remarkably since the implementation of NI 58-101 and the CSA’s inaugural review. The CSA expects this to be its final gender diversity review under the current disclosure standards as it continues to work towards a harmonized national disclosure framework.
Issuers should expect continued scrutiny of diversity practices and disclosure from proxy advisory firms, the CSA and investors.
For further information regarding this update and diversity requirements, please contact any member of our Capital Markets Group.
Expertise
Authors
Insights
-
Capital Markets
CSA Finalizes Amendments to Align Non-GAAP Financial Measures Disclosure Framework with IFRS 18
On October 15, 2026, the Canadian Securities Administrators (CSA) published final amendments to National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure (“NI 52-112”) and… -
Banking and Finance
Deleveraging During a Proxy Contest: Lessons from the BC Securities Commission’s Decision in Zefiro
The British Columbia Securities Commission (BCSC) recently released its reasons in Re Zefiro Methane Corp., in which it declined to rescind a share issuance that Zefiro Methane Corp. (“Zefiro… -
REITs
The Legal Industry Reviews Edition 11 - REITs Chapter
Bill Gorman, Brenda Gosselin, and Stephen Pincus have co-authored The Canadian REIT Structure in the 11th edition of The Legal Industry Reviews Canada.In this chapter, they examine the evolution of… -
Capital Markets
CSA Proposes Broad Amendments to the Issuer Bid, Take-Over Bid and Beneficial Ownership Reporting Regimes
The Canadian Securities Administrators (CSA) published a notice and request for comment on a broad package of proposed amendments to Canada’s issuer bid, take-over bid and early warning reporting… -
REITs
The Legal Industry Reviews Edition 10 - REITs Chapter
Bill Gorman, Brenda Gosselin, and Stephen Pincus have co-authored The Canadian REIT Structure in the 10th edition of The Legal Industry Reviews Canada.In this chapter, they examine the evolution of… -
Capital Markets
Canadian Securities Administrators Adopt Semi-Annual Reporting Pilot Project
On March 19, 2026, the Canadian Securities Administrators (CSA) announced the adoption of a pilot project (the “SAR Pilot”) that permits eligible venture issuers to voluntarily report on a…
Featured Work
-
Capital Markets
CIBC Capital leads C$400 million Oxford Properties Group Trust debt offering
Goodmans LLP acted for CIBC Capital Markets, as Lead Left Joint Bookrunner, and the agents in connection with a C$400 million senior unsecured notes offering for Oxford Properties Group Trust (“OPGT… -
Banking and Finance
Vital Infrastructure Property Trust completes C$300 million senior unsecured debentures offering
Goodmans LLP acted for Vital Infrastructure Property Trust in connection with its private placement offering of C$300 million aggregate principal amount of 4.865% Series C senior unsecured debentures… -
Capital Markets
Apotex Health Corp. closes $1.25 billion inaugural senior unsecured notes offering
Goodmans LLP acted for Apotex Health Corp. in connection with its private placement offering of $1.25 billion aggregate principal amount of senior unsecured notes… -
Entertainment
WildBrain announces a C$20 million substantial issuer bid
Goodmans LLP is acting for WildBrain Ltd. in connection with its substantial issuer bid to purchase, for cancellation, a number of common shares of the company for an aggregate purchase price not… -
Capital Markets
Apotex Health Corp. completes upsized $850 million bought deal secondary offering
Goodmans LLP acted for Apotex Health Corp. in connection with the closing of the upsized bought deal secondary offering of its common shares by an affiliate of SK Capital Partners, API Investment LP… -
Mergers and Acquisitions
Onex Partners and co-investors acquire AirSprint
Goodmans LLP acted as M&A legal counsel to Onex Partners in connection with the acquisition of AirSprint Inc. by Onex and its co-investors…
News & Events
-
Banking and Finance
Goodmans Recognized in the Best Law Firms - Canada 2027
Goodmans is pleased to be featured in the Best Law Firms - Canada 2027, recognizing us as one of Canada’s most exceptional law firms across 41 industries and practices.We are also honoured to be… -
Aging and Healthcare
Goodmans Honoured with Top-Tier Recognition from Chambers
We are proud to announce Goodmans has received top-tier recognition from Chambers in the Chambers Canada 2027 Guide. Recognition from Chambers is based on independent research and direct client… -
Capital Markets
Goodmans Welcomes Dominique Carli
Goodmans is delighted to announce Dominique Carli has joined the firm as an Associate. Dom’s practice focuses on various areas of corporate law including mergers and acquisitions, private equity…